KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Receivables (2016 - 2025)

LifeMD's Receivables history spans 14 years, with the latest figure at $9.3 million for Q4 2025.

  • For Q4 2025, Receivables fell 11.0% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, down 11.0%, while the annual FY2025 figure was $9.3 million, 11.0% down from the prior year.
  • Receivables reached $9.3 million in Q4 2025 per LFMD's latest filing, up from $9.2 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $10.5 million in Q4 2024 to a low of $980055.0 in Q4 2021.
  • Average Receivables over 5 years is $4.8 million, with a median of $4.0 million recorded in 2023.
  • Peak YoY movement for Receivables: soared 789.11% in 2021, then dropped 11.0% in 2025.
  • A 5-year view of Receivables shows it stood at $980055.0 in 2021, then surged by 189.24% to $2.8 million in 2022, then skyrocketed by 121.03% to $6.3 million in 2023, then skyrocketed by 66.87% to $10.5 million in 2024, then decreased by 11.0% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Receivables are $9.3 million (Q4 2025), $9.2 million (Q3 2025), and $7.3 million (Q2 2025).